Phagocytosis of viable Candida albicans by alveolar macrophages: flow cytometric quantification.
The phagocytic capacity of blood leukocytes may be assessed by flow cytometric techniques using fluorochrome-labeled particles including viable microorganisms. Application of this approach to alveolar macrophages (AM) is hampered or even rendered impossible by the strong autofluorescence of this cell type, superimposing the fluorescence intensity of the labeled phagocytic targets. Viable Candida albicans were loaded with the membrane-permeable fluorescent dye carboxy-seminaphtorhodafluor 2/acetoxymethylester (carboxy-SNARF 2-AM), which is cleaved intracellularly to generate the membrane-impermeable derivative carboxy-SNARF 2. Fluorescence was excited with the 488-nm line of an argon-ion laser, and the emission peak at 633 nm was used for quantification of dye-associated fluorescence. Rabbit and human AM were labeled with fluorescein isothiocyanate-coupled monoclonal mouse anti-macrophage antibodies. After coincubation of macrophages and yeast, 4% paraformaldehyde plus 0.5% EDTA in phosphate-buffered saline was used to stop the phagocytic process and detach adherent yeast from the AM surface. Macrophages loaded with yeast displayed a shift from monochromatic (green) to dual (green and red) fluorescence. The percentage of yeast-positive AM and red fluorescence intensity of phagocytosing macrophages were quantified. Yeast opsonization with serum or anti-Candida immunoglobulins was a prerequisite for phagocytosis. Under optimized conditions (0.5-10% serum; 60 min yeast-AM incubation; yeast-AM ratio 8:1 to 12:1), 71-91% of the AM were involved in the phagocytic process. Yeast engulfment was completely inhibited by N-ethylmaleimide and iodoacetic acid.(ABSTRACT TRUNCATED AT 250 WORDS)
Rosseau
S
S
Department of Internal Medicine, Justus-Liebig University, Giessen, Germany.
Seeger
W
W
Pralle
H
H
Lohmeyer
J
J
D000818:Animals; D001578:Benzopyrans; D002176:Candida albicans / Q000502:physiology; D005434:Flow Cytometry / Q000379:methods*; D006801:Humans; D016676:Macrophages, Alveolar / Q000502:physiology*; D009284:Naphthols; D010587:Phagocytosis; D011817:Rabbits; D012235:Rhodamines
D001578:Benzopyrans; D009284:Naphthols; D012235:Rhodamines; C088988:carboxy-seminaphtorhodafluor-2-acetoxymethyl ester